Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Untargeted metabolomics reveals sugar and homocysteine dysregulations in prodromal AD

View ORCID ProfileIhab Hajjar, Chang Liu, View ORCID ProfileDean P. Jones, View ORCID ProfileKaran Uppal
doi: https://doi.org/10.1101/2020.02.23.20025064
Ihab Hajjar
1Department of Neurology, Emory University, 6 Executive Park, Atlanta, GA 30329, Phone: (404) 712-1763, Email:
MD, MS
Roles: Associate Professor of Medicine and Neurology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ihab Hajjar
  • For correspondence: ihabhajjar{at}emory.edu ihabhajjar{at}emory.edu
Chang Liu
2Department of Medicine, Emory University
MPH
Roles: Bioinformatics Analyst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dean P. Jones
2Department of Medicine, Emory University
PhD
Roles: Professor of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dean P. Jones
Karan Uppal
2Department of Medicine, Emory University
PhD
Roles: Assistant Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karan Uppal
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Altered metabolism may occur early in Alzheimer’s disease (AD). We used untargeted high-resolution metabolomics in the cerebrospinal fluid (CSF) in mild cognitive impairment (MCI) to identify these alterations.

Methods CSF from 92 normal controls and 93 MCI underwent untargeted metabolomics using high-resolution mass spectrometry with liquid chromatography. Partial least squares discriminant analysis was used followed by metabolite annotation and pathway enrichment analysis (PES). Significant features were correlated with disease phenotypes using spearman correlation.

Results We identified 294 features differentially expressed between the 2 groups and 94 were annotated. PES showed that pathways related to sugar regulation (N-Glycan, p=0.0007; sialic acid, p=0.0014; Aminosugars, p=0.0042; galactose, p=0.0054) homocysteine regulation (p=0.0081) were differentially activated and significant features within these pathways correlated with disease phenotypes.

Conclusion We identified a metabolic signature characterized by impairments in sugar and homocysteine regulation in prodromal AD. Targeting these changes may offer new therapeutic approaches to AD

Research in Context

  1. Systematic review: The authors searched PUBMED and Google Scholar for previous reports of metabolomics and Alzheimer’s disease. Search Terms included: mild cognitive impairment, Alzheimer’s disease “AND” metabolism, metabolomics. This search identified multiple small studies that have conducted untargeted metabolomics in AD. This search resulted in the following findings: Prior studies have either included small samples, used targeted approaches, or focused on plasma profiling. In this study, we conducted a case-control untargeted high resolution metabolomic study on the CSF of a larger sample of normal cognition and mild cognitive impairment.

  2. Interpretation: We discovered that pathways in sugar metabolism, homocysteine and tyrosine were dysregulated in AD. Further, features that were significantly different between MCI and normal cognition had different patterns of association with cognitive, neuroimaging and Amyloid and tau biomarkers.

  3. Future direction: These pathways offer new potential targets for AD

Highlights

  • Metabolic signature is detectable in prodromal AD

  • Multiple sugar metabolism pathways are dysregulated in prodromal AD.

  • S-adenosylmethionine is under- and S-adenosylhomocysteine is overexpressed in AD

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Institutes of Health [Grants number RF1AG051633, RF1AG057470, R01AG049752, R01AG042127

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • chang.liu2{at}emory.edu, Email: dpjones{at}emory.edu, kuppal2{at}emory.edu

Data Availability

ALl data will be made available at SYNAPSE in 2020.

https://www.synapse.org/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted February 26, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Untargeted metabolomics reveals sugar and homocysteine dysregulations in prodromal AD
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Untargeted metabolomics reveals sugar and homocysteine dysregulations in prodromal AD
Ihab Hajjar, Chang Liu, Dean P. Jones, Karan Uppal
medRxiv 2020.02.23.20025064; doi: https://doi.org/10.1101/2020.02.23.20025064
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Untargeted metabolomics reveals sugar and homocysteine dysregulations in prodromal AD
Ihab Hajjar, Chang Liu, Dean P. Jones, Karan Uppal
medRxiv 2020.02.23.20025064; doi: https://doi.org/10.1101/2020.02.23.20025064

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)